Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age	Alzheimer's Disease Dementia; Mild Cognitive Impairment Due to Alzheimer's Disease	Active, not recruiting	Phase 2	2026-06-30		NCT05399888

Clinical trials